Articles tagged as


-Since our report ran 12 months ago WW’s stock has sharply outperformed the market -COVID-19 is accelerating WW move to digital subscriptions, which could help margins As US economy recovers, if subscribers continue to rise; WW stock could rise 30%-40% A year has passed since I wrote about WW International (WW), formerly Weight Watchers (A Battered Weight Watchers Stock Looks Inexpensive, July 10, 2019).  I’m happy to report that since our piece was published its stock is up 20% to $25.73 recently, outperforming the Standard & Poor’s 500 index, up 8% over the same period. Of course, the 12 months in between has been hair raising.  While the broad market, down 35% in March, has recovered most of its losses, WW hasn’t. It is off 45%, mostly on COVID-19 fear, from $47 in January. I should have taken a victory lap then!  Source: FSInsight. com, Bloomberg I still favor WW shares and it could return to the mid $30s, or up 30%-40%.  (More on the valuation below.) The company continues to make slow but steady progress under CEO Mindy Grossman, who came aboard three years ago and is modernizing WW to a “wellness” firm from an old-fashioned “diet” company.  WW was already moving to a big emphasis on a digital approach from the traditional studio approach—where customers would physically come in—even before coronavirus hit.  Here are WW’s latest results:  The company finished 2019 with 4.2 million subscribers, a record level for a year-end and up 8% from the end of 2018, with subscriber growth in all its major geographic markets. Revenues in fiscal 2019 were $1.4 billion, down 5%, while net income was $120 million or $1.72, down from $224 million or $3.19 in 2018. The profit comp is skewed by a higher tax rate, 21% in 2019 vs 8% in 2018, and one-time benefits/charges swing of 55 cents favoring 2018.  Slow and steady improvements are seen in the first quarter, as subs rose 9% year-over-year to 5 million, an all-time Q1 high. Revenues rose 10% from the year ago quarter to $400 million. Operating income rose 14% to $25 million, primarily driven by leverage on higher revenues from digital subscriptions. The net loss narrowed to $6.1 million, or 9 cents, from to $10.7 million, or 16 cents, in the prior year period. Debt net of cash was $1.4 billion at March end and adjusted Ebitda for the past 12 months was $358 million. Debt/Ebitda leverage has fallen to about 4 times from 4.5 and will likely drop further. WW is introducing cost cuts of $100 million in reaction to COVID-19.                                                                                                                                                                       As you might expect, COVID-19 is not helping WW’s studio/store business, as is plain from this statistic: in the first quarter digital subscribers rose 16%, but studio plus digital subscribers, fell 5%. The unforeseeable spread of COVID-19 put a small dent in my thesis, at least to the extent that studio visits and attendant product sales are down. It forced the company to withdraw its previous February 2020 guidance of revenues approaching $1.6 billion and EPS range of $2.15 to $2.40.  However, I think the guidance—even withdrawn—is instructive for an investor who wants to get a fix on WW post COVID-19.  Indeed, I think that COVID-19 will speed up the move to digital at WW and more quickly improve results long term.  For example, Zacks Investment Research, in a June 16 report, pointed out that WW “robust” digital business is courtesy of the social distancing and the focus on digital transformation. On June 15, WW said that it had 4.9 million subscribers as of June 6, up 7% from June 8, 2019, consisting of 3.8 million digital subs and 1.1 million studio plus digital subs. (Please note WW’s business is seasonal, with results trailing down from the typically strongest 1Q.) The company also said that starting mid-April, digital recruitment trends returned to growth and have accelerated, and are now trending ahead of the first quarter, prior to the escalation of COVID-19 mid-March. Approximately 90% of recruits since mid-March come from the digital business. Though the studio business continues to see significant declines, WW has begun reopening locations in a phased manner and anticipates 400 reopened in the U.S. last month. WW is increasingly transforming into a capital light business, with three main tailwinds, says Marshall Kaplan, who leads the Fundamental Equity Advisors, a team at Ingalls & Snyder, LLC, which recently bought WW shares.  It’s a timely idea because the pandemic has focused Americans on health and weight control, he notes.  As I wrote last year, obesity is a worldwide problem and getting worse. The Centers for Disease Control and Prevention estimates over 36% of US adults are obese. Source: Company reports Kaplan’s view is seconded by a recent report from Morgan Stanley, which said the accelerating digital business is driven by consumers’ increasing wellness focus post COVID-19 restrictions. It cited a Nutrisystem-sponsored survey of 2,000 Americans, which found 63% of people place more of a priority on improving their diet and 76% of Americans say they gained up to 16 pounds during isolation. Wow! Second, adds Kaplan, WW’s focus on its digital business shows.  2Q is usually a slower period for WW, and the 3Q might be difficult too, given COVID-19, yet the company’s recent update shows downloads of its app are strong. Thirdly, Kaplan likes the company’s plans to launch virtual group coaching worldwide, probably in the fourth quarter.  If it significantly supersedes full time studio coaches, it could improve margins through higher utilization of coaching and potentially significant savings in real estate, if fewer physical locations are needed. Though the stock is up from a year ago, the valuation is not. It trades at 11.7 times consensus EPS of $2.21 next year (vs $1.73 this year), compared to a 12 times PE one year ago. If the company progresses on its plans, its PE could approach its historical PE median of 14-15 times. If applied to the EPS consensus of $2.46 in 2022, that could yield a $35 stock price longer term. Meanwhile, shares of weight loss product distributor Medifast (MED) have tripled since March lows, but WW’s have only doubled from lows.  Then there is the not so secret weapon Oprah Winfrey, who actively markets WW and will likely continue that. She is a director with about an 8% stake. Our head of global portfolio analysis, Brian Rauscher, says his Analyst Sentiment Measure (ASM) at WW has positively inflected, and analyst EPS reductions continue to get smaller. The combination of these two metrics historically has boded well for a stock.  Where I could be wrong: No one can predict how the COVID-19 spread will play out or when it will end. Even with strong cash flow, WW remains somewhat leveraged. Bottom Line: COVID-19 is accelerating a move to digital subscriptions. As WW continues its modernization to a “wellness” and digital company, the EPS should rise and the share price along with it. Prior “Signals”     DateTopicSubject / TickerThe Signal7/22/20StockXilinx (XLNX)If EPS Rises to Pre-Covid-19 Level, XLNX Could See Old Highs7/15/20StockMarket ConcentrationNarrow Mkt Rally Fuels Worry; We Expect Cyclicals To Join7/8/20StockSEC FilingsOther Voices: Why Reading 10K Filings Is Crucial; Part 17/1/20StockSimply Good Foods (SMPL)Post-COVID-19, Simply Good Foods Stock Looks Appetizing6/24/20StockLam Research, Applied MaterialsLam Research, Applied Materials Set to Reap IoT Harvest6/17/20StockNordic Semiconductor (Nod. NO)Continued IoT Growth Good News for Nordic Semiconductor6/10/20StockHelmerich & Payne (HP)Helmerich & Payne Stock Could Energize Your Portfolio6/3/20OptionsVan Hulzen Asset ManagementFor Income Seekers, Why Covered Calls Top Junk Bond ETFs5/27/20StockJP Morgan Chase (JPM)Why JPMorgan Chase Belongs in Portfolios Post-COVID-195/20/20StockHorizon (HZNP)Horizon Therapeutics Is Inexpensive; 2 Drugs Show Promise5/13/20StockBank OZK (OZK)‘Plain Vanilla’ Bank OZK Could Be Long Term Opportunity5/6/20StockGraham Holdings (GHC)Post COVID-19, Graham Holdings Could Return to Growth4/29/20StockPacira (PCRX)Pacira To Benefit from Surgery Trend Away from Opioids4/22/20StockAvalara (AVLR)Avalara Stock Could Benefit from Catalysts Boosting Amazon4/15/20StockFirst Republic (FRC)First Republic Stock Looks Cheap in Post COVID-19 World4/8/20StockGalapagos (GLPG)If Galapagos Arthritis Drug Is Approved, Stock Looks Cheap4/1/20StockDaVita (DVA)In Uncertain Markets, DaVita’s Stable Rev/EPS Look Attractive

  • Signal from Noise
Jul 10, 2019

A Battered Weight Watchers' Stock Looks Inexpensive

Shares of WW International, formerly Weight Watchers (WW) have been battered for some time now, even after accounting for a 25% rise from lows recently. It’s a value stock. No, don’t leave. Stay with me here. I realize that currently most investors would prefer a hot poker in the eye to a value stock. I get it. Nevertheless, WW’s stock could offer a healthy (sorry had to say it) return if things continue to improve as they have lately. In Wall Streetese WW looks to have more upside than downside. Why is the stock not liked? It’s viewed by some as an oldfashioned “diet” company, when these days people lose weight with apps, DYI websites, and electronic wrist devices. The latest popular method is the Ketogenic diet, effectively yet another low-carb diet. To me it seems like just another fad, whereas WW has stood the test of time. The shorts are all over WW, with 10 million of the 67 million shares old short. They are comparing WW to Kodak. The analyst at JP Morgan, previously a big fan, “threw in the towel” on WW back in January, moving it to “Neutral” rating from a “Buy.” Indeed, of the 14 brokerage analysts who follow it, only 2 have Buy ratings. That kind of lopsided sentiment makes me take notice. When Wall Street leans hard one way on a stock, if it is wrong—and the herd often is—it takes time for the consensus to notice changes and the return to investors can be handsome. With volatile moves up and down, the stock is down about 12% since the end of 2014 while the market is up about 45%. Midcaps are up 34%. What should interest investors is the early signs WW shows of turning things around. In the first quarter, revenue was $363 million, a bit shy of expectations of $366, but the loss of 16 cents per share was much better than expectations of 26 cents in red ink. WW is focusing on wellness solutions as well as weight management, and the company raised its EPS guidance to $1.35-$1.55 from prior view of $1.25-$1.50. The stock jumped 20% in response but has given much of that back. Part of WW’s renaissance has to do with its’ recent move from just a “diet” to a wellness company, hence the WW moniker. If management can continue increasing member recruitment and retention—up 22% last year—the stock can continue to recover. Is there room for a company that asks you to come to meetings and weigh yourself? There’s one thing right with the latter: studies have shown it works. Earlier this year, the U.S. News & World Report found that out of 41 diets evaluated, WW’s was ranked first in “Best Weight Loss” and in “Best Commercial Diet Plans.” It ranked second as “Easiest Diet to Follow.” Additionally, studies over time have shown that meeting attendance is the strongest predictor of weight loss compared to other methods. Apps just can’t compete with the personal interaction that comes with a meetings plan. It’s true that meeting fee per attendance has been declining for a while but digital revenue is growing substantially, up 36% in 2018. Unfortunately, obesity is a worldwide problem and getting worse. According to the Centers for Disease Control and Prevention, estimates over 36% of US adults are obese. No state has an obesity rate below 20%. That trend continues to rise and around the world the combined global prevalence of obesity and overweight people could exceed 40% of the total by 2030, the World Health Organization says. WW stock doesn’t look expensive compared to the industry or its own history. Again, this is a value stock, and, moreover, improvement will take time. According to Zacks Investment Research, which ranks it a Strong Buy, the P/E ratio of 12 compares to 16 for the industry. That’s a nice discount, and a 12 handle can’t be called rich. The median P/E is about 14 to 16. The price to earnings growth ratio, or PEG, is 0.98, versus an industry average PEG of 1.31 (See table). Next year analysts expect EPS of $1.89, a 24% rise from 2019 and more like the growth clocked in 2016-18. Source: Zacks The technical picture looks good, too, according to our very own head of technical strategy, Robert Sluymer. After declining over 80% from its $105 highs to lows near $17, WW is showing early signs of bottoming, around $22 in March. WW is in a $17- $24 trading range, and been building positively since, with higher lows in place, an early indication of a new uptrend developing. Then there is the possible catalyst by the name of Oprah Winfrey, who owns an 8% stake in WW and gave the stock a big lift back in 2015 when she originally bought shares. Her deal with Apple TV Plus streaming, with a full rollout in the fall to 100 countries, has gotten WW bulls excited. Right now, there’s not much to talk about, but as she herself noted, “I’m joining forces with Apple. They’re in a billion pockets, y’all.” The potential here, and admittedly it’s just that, could be impressive. Of course, the stock isn’t perfect, hence the value. There is some debt: $1.7 billion, down from $2.4 billion a few years ago, thanks to strong cash flow. Net of cash, it’s levered about 4.5 times EBITDA, according to Bloomberg Intelligence. As cash flow grows, WW can continue to reduce leverage. Bottom Line: And if the stock begins to move, a nice little short squeeze could add fuel to the fire

FSInsight logo
150 East 52nd St, 3rd Floor, New York, NY 10022

Subscribe to our Free Weekly Report

An insitutional-grade report delivered to your inbox every week.

© 2020 FSInsight. All rights reserved. Developed by HANGAR115.

Illustrations by Karl Wimer.